MedTrace Logo

Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries

NCT04261036 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2023-05-30

No results posted yet for this study

Summary

This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.

Conditions

  • Catheter-Associated Urinary Tract Infection, Ascorbic Acid

Interventions

DRUG

Ascorbic Acid 1000 mg

1000 mg ascorbic acid (Vitamin C) for 14 days post-op after an elective gynecological surgery.

OTHER

Placebo

Placebo pills for 14 days post-op after an elective gynecological surgery.

Sponsors & Collaborators

  • American University of Beirut Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-20
Primary Completion
2021-07-01
Completion
2021-10-01
FDA Drug
Yes

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04261036 on ClinicalTrials.gov